Clinical data | |
---|---|
Trade names | Cervagem |
Other names | methyl (E)-7--5-oxo-cyclopentyl]hept-2-enoate |
AHFS/Drugs.com | International Drug Names |
Pregnancy category |
|
Routes of administration | Pessary |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.058.869 |
Chemical and physical data | |
Formula | C23H38O5 |
Molar mass | 394.552 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(what is this?) (verify) |
Gemeprost (16, 16-dimethyl-trans-delta2 PGE1 methyl ester) is an analogue of prostaglandin E1.
Clinical use
It is used as a treatment for obstetric bleeding.
It is used with mifepristone to terminate pregnancy up to 24 weeks gestation.
Side effects
Vaginal bleeding, cramps, nausea, vomiting, loose stools or diarrhea, headache, muscle weakness; dizziness; flushing; chills; backache; dyspnoea; chest pain; palpitations and mild pyrexia. Rare: Uterine rupture, severe hypotension, coronary spasms with subsequent myocardial infarctions.
References
- "Cervagem 1 mg Pessary - Summary of Product Characteristics (SmPC)". (emc). 16 August 2019. Retrieved 7 September 2020.
- Bartley J, Brown A, Elton R, Baird DT (October 2001). "Double-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation". Human Reproduction. 16 (10): 2098–102. doi:10.1093/humrep/16.10.2098. PMID 11574498.
- ^ Aronson, J. K. (2015). Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. Elsevier Science. p. 524. ISBN 978-0-4445-3716-4.
External links
- "Gemeprost". Drug Information Portal. U.S. National Library of Medicine.
Eicosanoids | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Precursor | |||||||||||||||
Prostanoids |
| ||||||||||||||
Leukotrienes (LT) |
| ||||||||||||||
Eoxins (EX) |
| ||||||||||||||
Nonclassic |
| ||||||||||||||
By function |
Uterotonics/labor inducers/oxytocics (G02A) | |||||
---|---|---|---|---|---|
Cervical ripening |
| ||||
Contraction induction | |||||
|
This drug article relating to the genito-urinary system is a stub. You can help Misplaced Pages by expanding it. |